Publication Information

{'id': 'https://openalex.org/W2795108457', 'doi': 'https://doi.org/10.5167/uzh-46231', 'title': 'Acquired vorinostat resistance shows partial cross-resistance to "second-generation" HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities', 'display_name': 'Acquired vorinostat resistance shows partial cross-resistance to "second-generation" HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities', 'publication_year': 2010, 'publication_date': '2010-01-01', 'ids': {'openalex': 'https://openalex.org/W2795108457', 'doi': 'https://doi.org/10.5167/uzh-46231', 'mag': '2795108457'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.zora.uzh.ch/46231/', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'dissertation', 'type_crossref': 'dissertation', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5004978088', 'display_name': 'Jennifer Dedes', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'J Dedes', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5004978088'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.983, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/romidepsin', 'display_name': 'Romidepsin', 'score': 0.9705614}, {'id': 'https://openalex.org/keywords/vorinostat', 'display_name': 'Vorinostat', 'score': 0.91915864}, {'id': 'https://openalex.org/keywords/histone-deacetylase-inhibitor', 'display_name': 'Histone deacetylase inhibitor', 'score': 0.44001758}], 'concepts': [{'id': 'https://openalex.org/C2781462825', 'wikidata': 'https://www.wikidata.org/wiki/Q7363205', 'display_name': 'Romidepsin', 'level': 5, 'score': 0.9705614}, {'id': 'https://openalex.org/C2776262904', 'wikidata': 'https://www.wikidata.org/wiki/Q905901', 'display_name': 'Vorinostat', 'level': 5, 'score': 0.91915864}, {'id': 'https://openalex.org/C119157956', 'wikidata': 'https://www.wikidata.org/wiki/Q796604', 'display_name': 'Acetylation', 'level': 3, 'score': 0.75844055}, {'id': 'https://openalex.org/C2778305200', 'wikidata': 'https://www.wikidata.org/wiki/Q174378', 'display_name': 'Histone deacetylase', 'level': 4, 'score': 0.5751842}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.54057926}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.53919387}, {'id': 'https://openalex.org/C2776202225', 'wikidata': 'https://www.wikidata.org/wiki/Q3569101', 'display_name': 'Histone deacetylase inhibitor', 'level': 5, 'score': 0.44001758}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.4232108}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.41534692}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.32621777}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.21608326}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.049292356}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.zora.uzh.ch/46231/', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.86, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3203251457', 'https://openalex.org/W3189291204', 'https://openalex.org/W3030186732', 'https://openalex.org/W2967849197', 'https://openalex.org/W2932314044', 'https://openalex.org/W2912544293', 'https://openalex.org/W2886726729', 'https://openalex.org/W2762816142', 'https://openalex.org/W2573139360', 'https://openalex.org/W2410338270', 'https://openalex.org/W2281845582', 'https://openalex.org/W2176988486', 'https://openalex.org/W2144110273', 'https://openalex.org/W2125262261', 'https://openalex.org/W2055588591', 'https://openalex.org/W2042806682', 'https://openalex.org/W2038311942', 'https://openalex.org/W2022415712', 'https://openalex.org/W2004288940', 'https://openalex.org/W1979050658'], 'abstract_inverted_index': {'Histonedeacetylase(HDAC)inhibitors': [0], 'such': [1], 'as': [2], 'vorinostat': [3, 26], '(suberoylanilide': [4], 'hydroxamicacid),': [5], 'valproicacid,romidepsin': [6], '(FK-228),': [7], 'and': [8, 48, 70, 79, 85, 99], 'LBH589': [9], 'comprise': [10], 'a': [11], 'relatively': [12], 'new': [13], 'class': [14], 'of': [15, 25, 30, 53, 63, 65, 74, 82], 'potentanti': [16], 'canceragents.': [17], 'This': [18, 41, 89], 'study': [19], 'provides': [20], 'evidence': [21], 'for': [22], 'the': [23, 51, 61, 72, 75, 80, 97, 102, 108], 'potential': [24], 'to': [27, 96, 101], 'cause': [28], 'acquisition': [29], 'multi': [31], 'drug': [32], 'resistance': [33, 35, 43, 91, 117], 'protein-independent': [34], 'in': [36], 'HCT116': [37], 'colon': [38], 'tumor': [39], 'cells.': [40], 'acquired': [42, 90, 114], 'is': [44, 46, 60], 'moderate(two-foldtothree-fold),': [45], 'non-reversible,': [47], 'correlates': [49], 'with': [50, 57, 94], 'loss': [52, 62, 73, 81], 'responses': [54], 'typically': [55], 'seen': [56], 'HDAC-inhibitors,': [58], 'that': [59], 'acetylation': [64], 'thehistones': [66], 'H2A,': [67], 'H2B,': [68], 'H3,': [69], 'H4,': [71], 'G2/M': [76], 'checkpoint': [77], 'activation,': [78], 'caspase': [83, 86], '3-dependent': [84], '7-dependent': [87], 'apoptosis.': [88], 'also': [92], 'associates': [93], 'cross-resistance': [95], 'hydroxamate-class(LBH589': [98], 'JNJ26481585)and': [100], 'aliphaticacid-class(valproicacid)HDAC': [103], 'inhibitors': [104], 'but': [105], 'not': [106], 'tothebenzamide-class(MGCD0103)and': [107], 'cyclic': [109], 'peptide-class(romidepsin)': [110], 'HDAC': [111, 115], 'inhibitors.': [112], 'The': [113], 'inhibitor': [116], 'described': [118], 'here.': [119]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2795108457', 'counts_by_year': [], 'updated_date': '2024-12-08T14:10:02.556875', 'created_date': '2018-04-06'}